Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
Primoris Services
PRIM
$4.26B
| $10.7M | ﹤0.01% |
137,909
+15,648
| +13% | +$1.06M |
2016 Q3
35 quarters
|
|
1527
StoneCo
STNE
$2.2B
| $10.7M | ﹤0.01% |
669,091
+166,239
| +33% | +$2.22M |
2018 Q4
26 quarters
|
|
1528
Radian Group
RDN
$4.31B
| $10.7M | ﹤0.01% |
297,213
+76,918
| +35% | +$2.57M |
2013 Q2
48 quarters
|
|
1529
Qfin Holdings
QFIN
$785M
| $10.7M | ﹤0.01% |
246,520
+136,329
| +124% | +$5.68M |
2020 Q2
20 quarters
|
|
1530
HF Sinclair
DINO
$20.2B
| $10.7M | ﹤0.01% |
260,040
+63,062
| +32% | +$2.17M |
2013 Q2
48 quarters
|
|
1531
Merit Medical Systems
MMSI
$5.1B
| $10.7M | ﹤0.01% |
114,038
-15,831
| -12% | -$1.5M |
2016 Q1
37 quarters
|
|
1532
Insperity
NSP
$1.78B
| $10.7M | ﹤0.01% |
177,304
+30,457
| +21% | +$2.13M |
2016 Q1
37 quarters
|
|
1533
LCI Industries
LCII
$2.01B
| $10.6M | ﹤0.01% |
116,781
-69,369
| -37% | -$5.92M |
2016 Q1
37 quarters
|
|
1534
New Jersey Resources
NJR
$5.23B
| $10.6M | ﹤0.01% |
237,484
+66,752
| +39% | +$3.13M |
2013 Q2
48 quarters
|
|
1535
Planet Fitness
PLNT
$3.2B
| $10.6M | ﹤0.01% |
97,536
+50,277
| +106% | +$5.03M |
2015 Q3
39 quarters
|
|
1536
Southern Copper
SCCO
$174B
| $10.6M | ﹤0.01% |
109,775
+44,417
| +68% | +$3.86M |
2013 Q2
48 quarters
|
|
1537
Tandem Diabetes Care
TNDM
$1.15B
| $10.6M | ﹤0.01% |
567,072
+53,066
| +10% | +$1.05M |
2017 Q4
30 quarters
|
|
|
RNAM
1538
DELISTED
Avidity Biosciences
RNAM
| $10.6M | ﹤0.01% |
371,770
+47,875
| +15% | +$1.43M |
2022 Q1
13 quarters
|
|
1539
PUT
CrowdStrike
CRWD
$277B
| $10.5M | ﹤0.01% |
82,800
-121,200
| -59% | -$13.1M |
2024 Q3
3 quarters
|
|
1540
CALL
Applovin
APP
$89.8B
| $10.5M | ﹤0.01% |
30,100
-52,400
| -64% | -$17M |
2024 Q4
2 quarters
|
|
1541
Ormat Technologies
ORA
$5.71B
| $10.5M | ﹤0.01% |
125,639
+41,882
| +50% | +$3.13M |
2013 Q2
48 quarters
|
|
1542
Construction Partners
ROAD
$5.17B
| $10.5M | ﹤0.01% |
98,904
+34,757
| +54% | +$3.25M |
2019 Q2
24 quarters
|
|
1543
OneMain Financial
OMF
$6.44B
| $10.5M | ﹤0.01% |
184,364
-12,256
| -6% | -$611K |
2013 Q4
46 quarters
|
|
1544
US Foods
USFD
$21B
| $10.5M | ﹤0.01% |
136,130
+176
| +0.1% | +$12.6K |
2016 Q2
36 quarters
|
|
1545
ICICI Bank
IBN
$98.5B
| $10.5M | ﹤0.01% |
311,050
+46,790
| +18% | +$1.55M |
2013 Q2
48 quarters
|
|
|
VRNA
1546
DELISTED
Verona Pharma
VRNA
| $10.5M | ﹤0.01% |
110,611
+1,110
| +1% | +$82.2K |
2024 Q3
3 quarters
|
|
1547
Ameris Bancorp
ABCB
$5.47B
| $10.5M | ﹤0.01% |
161,631
+51,242
| +46% | +$3.04M |
2016 Q1
37 quarters
|
|
1548
Knife River
KNF
$2.86B
| $10.5M | ﹤0.01% |
128,034
+37,713
| +42% | +$3.43M |
2023 Q2
8 quarters
|
|
1549
Mercury Systems
MRCY
$5.17B
| $10.4M | ﹤0.01% |
193,468
+40,681
| +27% | +$1.98M |
2016 Q1
37 quarters
|
|
1550
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
| $10.4M | ﹤0.01% |
+175,400
| New | +$9.77M |
2025 Q2
0 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.